BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 35979438)

  • 1. Impact of preexisting diabetes mellitus on cardiovascular and all-cause mortality in patients with atrial fibrillation: A meta-analysis.
    Xu J; Sun Y; Gong D; Fan Y
    Front Endocrinol (Lausanne); 2022; 13():921159. PubMed ID: 35979438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of frailty on all-cause mortality and major bleeding in patients with atrial fibrillation: A meta-analysis.
    He L; He R; Huang J; Zou C; Fan Y
    Ageing Res Rev; 2022 Jan; 73():101527. PubMed ID: 34839042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes mellitus, blood glucose and the risk of atrial fibrillation: A systematic review and meta-analysis of cohort studies.
    Aune D; Feng T; Schlesinger S; Janszky I; Norat T; Riboli E
    J Diabetes Complications; 2018 May; 32(5):501-511. PubMed ID: 29653902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The presence of atrial fibrillation in Takotsubo cardiomyopathy is predictive of mortality: Systematic review and meta-analysis.
    Prasitlumkum N; Kittipibul V; Limpruttidham N; Rattanawong P; Chongsathidkiet P; Boondarikpornpant T
    Ann Noninvasive Electrocardiol; 2019 Jan; 24(1):e12566. PubMed ID: 29938868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of chronic obstructive pulmonary disease on prognosis in atrial fibrillation: A report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry.
    Proietti M; Laroche C; Drozd M; Vijgen J; Cozma DC; Drozdz J; Maggioni AP; Boriani G; Lip GY;
    Am Heart J; 2016 Nov; 181():83-91. PubMed ID: 27823697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of type 1 diabetes mellitus and risk of atrial fibrillation: Systematic review and meta-analysis.
    Guo S; Huang Y; Liu X; Ma J; Zhu W
    Diabetes Res Clin Pract; 2023 May; 199():110629. PubMed ID: 36948422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β-blockers and risk of all-cause mortality in patients with chronic heart failure and atrial fibrillation-a meta-analysis.
    Xu T; Huang Y; Zhou H; Bai Y; Huang X; Hu Y; Xu D; Zhang Y; Zhang J
    BMC Cardiovasc Disord; 2019 Jun; 19(1):135. PubMed ID: 31159740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Safety and Efficacy of Rivaroxaban Compared with Warfarin in Patients with Atrial Fibrillation and Diabetes: A Systematic Review and Meta-analysis.
    Hua Y; Sun JY; Su Y; Qu Q; Wang HY; Sun W; Kong XQ
    Am J Cardiovasc Drugs; 2021 Jan; 21(1):51-61. PubMed ID: 32514866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial fibrillation is associated with sudden cardiac death: a systematic review and meta-analysis.
    Rattanawong P; Upala S; Riangwiwat T; Jaruvongvanich V; Sanguankeo A; Vutthikraivit W; Chung EH
    J Interv Card Electrophysiol; 2018 Mar; 51(2):91-104. PubMed ID: 29332241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycemic variability and the risk of atrial fibrillation: a meta-analysis.
    Li W; Wang Y; Zhong G
    Front Endocrinol (Lausanne); 2023; 14():1126581. PubMed ID: 37274320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compliance of atrial fibrillation treatment with the ABC pathway in patients with concomitant diabetes mellitus in the Middle East based on the Gulf SAFE registry.
    Domek M; Gumprecht J; Li YG; Proietti M; Rashed W; Al Qudaimi A; Gumprecht J; Zubaid M; Lip GYH
    Eur J Clin Invest; 2021 Mar; 51(3):e13385. PubMed ID: 32810282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin versus sulphonylureas for new onset atrial fibrillation and stroke in type 2 diabetes mellitus: a population-based study.
    Zhou J; Zhang G; Chang C; Chou OHI; Lee S; Leung KSK; Wong WT; Liu T; Wai AKC; Cheng SH; Zhang Q; Tse G
    Acta Diabetol; 2022 May; 59(5):697-709. PubMed ID: 35112189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systematic literature review and meta-analysis on the impact of COPD on atrial fibrillation patient outcome.
    Ye J; Yao P; Shi X; Yu X
    Heart Lung; 2022; 51():67-74. PubMed ID: 34740082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse outcomes in patients with atrial fibrillation and peripheral arterial disease: a report from the EURObservational research programme pilot survey on atrial fibrillation.
    Proietti M; Raparelli V; Laroche C; Dan GA; Janion M; Popescu R; Sinagra G; Vijgen J; Boriani G; Maggioni AP; Tavazzi L; Lip GYH;
    Europace; 2017 Sep; 19(9):1439-1448. PubMed ID: 27940934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender difference in association between diabetes mellitus and all-cause mortality in atrial fibrillation patients.
    Tian L; Yang YM; Zhu J; Zhang H; Shao XH
    J Diabetes Complications; 2022 Sep; 36(9):108265. PubMed ID: 35914400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes mellitus as risk factor for atrial fibrillation hospitalization: Incidence and outcomes over nine years in a region of Northern Italy.
    Staszewsky L; Cortesi L; Baviera M; Tettamanti M; Marzona I; Nobili A; Fortino I; Bortolotti A; Merlino L; Disertori M; Latini R; Roncaglioni MC
    Diabetes Res Clin Pract; 2015 Sep; 109(3):476-84. PubMed ID: 26220013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between smoking and adverse outcomes in patients with atrial fibrillation: A meta-analysis and systematic review.
    Zhu W; Guo L; Hong K
    Int J Cardiol; 2016 Nov; 222():289-294. PubMed ID: 27500755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between body mass index and mortality in atrial fibrillation patients with and without diabetes mellitus: Insights from a multicenter registry study in China.
    Lyu SQ; Yang YM; Zhu J; Wang J; Wu S; Zhang H; Shao XH; Ren JM
    Nutr Metab Cardiovasc Dis; 2020 Nov; 30(12):2242-2251. PubMed ID: 32900569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of diabetes with atrial fibrillation types: a systematic review and meta-analysis.
    Alijla F; Buttia C; Reichlin T; Razvi S; Minder B; Wilhelm M; Muka T; Franco OH; Bano A
    Cardiovasc Diabetol; 2021 Dec; 20(1):230. PubMed ID: 34876114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of dronedarone on all-cause mortality and on cardiovascular events in patients treated for atrial fibrillation: a meta-analysis of RCTs.
    De Vecchis R; Ariano C
    Minerva Cardioangiol; 2019 Apr; 67(2):163-171. PubMed ID: 30260141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.